Makya Iktos

Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO).

Alessandro Monge on LinkedIn: #ai #machinelearning #drugdiscovery #drugdesign #computationalchemistry

Makya Iktos

Yann Gaston-Mathe on LinkedIn: Iktos and Bayer Announce Collaboration to expand the use of Artificial…

Iktos sur LinkedIn : Makya

Iktos Secures €15.5 Million in Funding to Accelerate AI Drug Discovery

Drug Discovery using Artificial Intelligence

Iktos Raises €15.5M in Series A Funding - Funding SMEs

Iktos Announces Collaboration With Pfizer in AI for Drug Design - “We are proud to work with Pfizer and to have their scientists use our software in their early discovery programs”

American Chemical Society

Iktos teams up with Sygnature Discovery on development project - Drug Discovery World (DDW)